Additionally, pharmacologic inhibition of the Rho/MRTF pathway by the small-molecule CCG-203971 significantly reduced in vitro cellular migration and invasion [20,28], as well as in vivo lung metastasis in the RhoC-expressing NRAS mutant melanoma cell line SK-Mel-147 [20]. Here, RHO is linked to melanoma.